Ely Lilly Conference Call Notes (LLY)

Eli Lilly says "we see year gross margin as percent revenue declining... year R&D 'essentially flat'... on track for 2011 headcount, expense goals... no supply issues from Japan crisis... $400-$500M health care reform effect on year revenue."